Unscripted – The AMCP Podcast
Unscripted - The AMCP Podcast
Podcast Description
Welcome to Unscripted, the AMCP Podcast — a look inside managed care pharmacy. Listen in as experts explore the challenges, innovations, and opportunities shaping health care for millions of patients.
Podcast Insights
Content Themes
The podcast covers a range of topics including health policy, treatment innovations, and patient care challenges. Episodes delve into specific areas such as the management of inflammatory bowel disease with discussions on biologics, personalized medicine, and health disparities, while also addressing regulatory issues and upcoming drug policies.

Welcome to Unscripted, the AMCP Podcast — a look inside managed care pharmacy. Listen in as experts explore the challenges, innovations, and opportunities shaping health care for millions of patients.
In this last installment of our rare disease series, we speak with Angela Luong, PharmD, Senior Clinical Consultant at Pharmaceutical Strategies Group. Our discussion focuses on the burden of sickle cell disease, chronic pain management, limited treatment options, and the implications for managed care programs, including the use of data and care coordination to improve patient outcomes.
This activity is supported by an independent medical education grant from Agios Pharmaceuticals, Inc. AMCP offers CPE for this podcast through December 31, 2026. For additional information and to claim credit, please visit: The Power of Partnership: Bridging Patients and Payers in Sickle Cell Disease Management

Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.